After years of research and a lengthy regulatory approval process, Genus Pig Improvement Company (PIC) has received clearance from the U.S. Food and Drug Administration (FDA) for the gene edited PRRS-resistant pig (PRP) to be used in the U.S. food supply chain. Genus executives note this is a significant step toward commercialization in the U.S., however, approvals are still needed in key U.S. export markets, such as Mexico, Canada and Japan. The firm says it continues to make progress with regulators in these jurisdictions as well as with other international regulators, including China, Brazil, Colombia and, most recently, the Dominican Republic, where positive determinations for the PRRS-resistant pig have been approved. Colombia was the...